(Q37928495)

25 August 2017

1 reference

title

Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond (English)

1 reference

25 August 2017

0 references

Breno Satler Diniz

1

1 reference

PubMed ID

21898045

25 August 2017

Antonio Lucio Teixeira

series ordinal

2

1 reference

25 August 2017

7 September 2011

1 reference

25 August 2017

NeuroMolecular Medicine

1 reference

25 August 2017

13

1 reference

25 August 2017

4

1 reference

25 August 2017

217-222

1 reference

https://scigraph.springernature.com/pub.10.1007/s12017-011-8154-x

25 August 2017

0 references

cites work

Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Dual response of BDNF to sublethal concentrations of beta-amyloid peptides in cultured cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

The immediate early gene arc/arg3.1: regulation, mechanisms, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Adult neurogenesis is functionally associated with AD-like neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Oligomers of beta-amyloid peptide inhibit BDNF-induced arc expression in cultured cortical Neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Diagnosis and biomarkers of predementia in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

The GSK3 hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Amyloid beta up-regulates brain-derived neurotrophic factor production from astrocytes: rescue from amyloid beta-related neuritic degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Stage-dependent BDNF serum concentrations in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Decreased serum brain-derived neurotrophic factor levels in elderly korean with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Small molecule neurotrophin receptor ligands: novel strategies for targeting Alzheimer's disease mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Pathways towards and away from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

β-Amyloid impairs axonal BDNF retrograde trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Advances in small molecules promoting neurotrophic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Neurotrophin-regulated signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Neurogenesis in the aged and neurodegenerative brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

New insights into brain BDNF function in normal aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-011-8154-X

Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease.

21 January 2018

1 reference

12 December 2020

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects

1 reference

12 December 2020

Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity

1 reference

12 December 2020

Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease

1 reference

12 December 2020

The Alzheimer's disease mitochondrial cascade hypothesis

1 reference

12 December 2020

Neuropathology and the neuroinflammation idea

1 reference

12 December 2020

Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor

1 reference

12 December 2020

Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation.

1 reference

12 December 2020

Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons.

1 reference

12 December 2020

Neurotrophins and their receptors: a convergence point for many signalling pathways

1 reference

12 December 2020

Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons

1 reference

12 December 2020

Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han.

1 reference

12 December 2020

Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis

1 reference

12 December 2020

10.1007/S12017-011-8154-X

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21898045